MiMedx Group, Inc(NASDAQ:MDXG)

Latest On MiMedx Group, Inc (MDXG):

Updated on: March 18, 2021

Date/Time	Type	Description	Signal
2023-05-06 11:18 EST	News	MiMedx's Post-Q1 2023 Surge Could Result In Profit-Taking	N/A
2023-05-03 19:46 EST	News	MiMedx surges ~30% after Q1 revenue growth, cost controls drive down net loss	N/A
2023-05-03 06:37 EST	News	MiMedx Group, Inc. (MDXG) Q1 2023 Earnings Call Transcript	N/A
2023-05-02 18:35 EST	News	MiMedx Group GAAP EPS of -$0.06 beats by $0.03, revenue of $71.68M beats by $7.53M	N/A
2023-05-01 18:02 EST	News	MiMedx Group Q1 2023 Earnings Preview	N/A

About MiMedx Group, Inc (MDXG):

MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts. The company's patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. Its products include EpiFix, a semi-permeable protective barrier membrane product used for the treatment of chronic wounds, including diabetic foot ulcers, venous leg ulcers, pressure ulcers, and burns; AmnioFix, a semi-permeable protective barrier membrane product for the treatment of wounds related to surgical procedures; EpiCord and AmnioCord that are dehydrated human umbilical cord allografts intended for homologous applications; and read more... AmnioFill that consists of particles of connective tissue matrix derived from placental disc and placental membranes. The company's products have applications primarily in the areas of wound care, burn, surgical, and non-operative sports medicine sectors of healthcare. It also sells allografts for dental applications on an original equipment manufacturer basis. The company sells its products through direct sales force and independent sales agents, as well as through independent distributors primarily in the United States. MiMedx Group, Inc. is headquartered in Marietta, Georgia.

See Advanced Chart

General

Name MiMedx Group, Inc
Symbol MDXG
Type Common Stock
Exchange NASDAQ
Currency USD
Country USA
SectorHealthcare
IndustryMedical Devices
Full Time Employees 735
Last Split Factor3235:10000
Last Split Date2008-04-02
Fiscal Year EndDecember
IPO Date2007-08-22
Gic SectorHealth Care
Gic GroupPharmaceuticals, Biotechnology & Life Sciences
Gic IndustryBiotechnology
Gic SubIndustryBiotechnology
Web URLhttp://www.mimedx.com

Valuation

Price/Sales (Trailing 12 Mt.) 3.94
Price/Book (Most Recent Quarter) 85.59
Enterprise Value Revenue 3.86
Enterprise Value EBITDA 117.93

Financials

Most Recent Quarter 2020-12-31
Current Year EPS Estimate -$0.05
Next Year EPS Estimate $0.22
Profit Margin -20%
Operating Margin -18%
Return on Assets -15%
Return on Equity -78%
Revenue 248.23 million
Earnings Per Share $0.31
Revenue Per Share $2.29
Gross Profit 208.9 million
Quarterly Earnings Growth -10.3%

Highlights

Market Capitalization 980.21 million
EBITDA 7.71 million
PE Ratio 10.9
PEG Ratio 2.97
Analyst Target Price $16
Book Value Per Share $0.12

Share Statistics

Shares Outstanding 111.04 million
Shares Float 74.07 million
% Held by Insiders 637%
% Held by Institutions 12.1%
Shares Short 7.57 million
Shares Short Prior Month 7.54 million
Short Ratio 15.29
Short % of Float 9%
Short % of Shares Outstanding 7%

Technicals

Beta 1.66
52 Week High $11.44
52 Week Low $2.95
50 Day Moving Average 9.84
200 Day Moving Average 7.82

Dividends

Dividend Date N/A
ExDividend Date N/A
Dividend Yield 0%

MiMedx Group, Inc (MDXG) Dividend Calendar:

Show entries

Search:

Ex-Dividend Date	Payment Date	Record Date	Declared Date	Amount
No data available in table

Showing 0 to 0 of 0 entries

EPS

EPS Estimate

MiMedx Group, Inc (MDXG) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.

Show entries

Quarter Date	Report Date	Actual Revenue	Reported EPS	EPS Estimate	Deviation from Estimate
2020-12-31	2021-03-08	$68.55 million	-$0.17	-$0.05	-240%
2020-09-30	2020-11-04	$N/A	-$0.48
2020-06-30	2020-07-06	$53.65 million	-$0.04
2020-03-31	2020-06-30	$61.74 million	-$0.08	$0.00
2019-12-31	2020-03-31	$76.4 million	-$0.04	$0.11	-140.73%
2019-09-30	2019-12-31	$88.86 million	-$0.07
2019-06-30	2019-09-30	$67.44 million	$0.11
2019-03-31	2019-06-30	$66.56 million	-$0.16
2018-12-31	2019-03-31	$N/A	-$0.12	$0.00
2018-09-30	2018-12-31		-$0.33	$0.00

MiMedx Group, Inc (MDXG) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:

Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares

Cash Flow:

Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures

Balance Sheet:

Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

MiMedx Group, Inc (MDXG) Chart:

MiMedx Group, Inc (MDXG) News:

Below you will find a list of latest news for MiMedx Group, Inc (MDXG) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

MiMedx Group, Inc (MDXG) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date:

Options Type:

Moneyness:

Show entries

Search:

Expiration Date	Strike	Last Price	Type	Volume	Open Interest	Implied Volatility	In the Money	Change	Change Percent
2025-05-16	2.5	4.7	CALL	2	3	415.28	TRUE	-0.06	-0.01
2025-05-16	5	0	CALL	0	0	159.31	TRUE	0	0
2025-05-16	7.5	0	CALL	0	0	88.4	FALSE	0	0
2025-05-16	10	0	CALL	0	0	133	FALSE	0	0
2025-05-16	12.5	0	CALL	0	0	238.09	FALSE	0	0
2025-05-16	15	0	CALL	0	0	279.63	FALSE	0	0
2025-05-16	2.5	0	PUT	0	0	459.13	FALSE	0	0
2025-05-16	5	0.15	PUT	0	2	120.06	FALSE	0	0
2025-05-16	7.5	0	PUT	0	0	128.06	TRUE	0	0
2025-05-16	10	0	PUT	0	0	146.1	TRUE	0	0
2025-05-16	12.5	0	PUT	0	0	269.42	TRUE	0	0
2025-05-16	15	0	PUT	0	0	270.71	TRUE	0	0
2025-06-20	2.5	5	CALL	2	2	331.72	TRUE	-0.13	-0.03
2025-06-20	5	1.22	CALL	0	1	69.14	TRUE	0	0
2025-06-20	7.5	0.45	CALL	0	138	101.88	FALSE	0	0
2025-06-20	10	0.15	CALL	0	152	75.53	FALSE	0	0
2025-06-20	12.5	0.1	CALL	0	65	86.4	FALSE	0	0
2025-06-20	15	0	CALL	0	0	225.36	FALSE	0	0
2025-06-20	17.5	0	CALL	0	0	246.98	FALSE	0	0
2025-06-20	2.5	0	PUT	0	0	443.26	FALSE	0	0

Latest MDXG Trades:

Date	Shares	Price
Jun 13, 2022 7:59 PM EST	300	$3.175
Jun 13, 2022 7:59 PM EST	100	$3.175
Jun 13, 2022 7:59 PM EST	100	$3.175
Jun 13, 2022 7:59 PM EST	400	$3.175
Jun 13, 2022 7:59 PM EST	2	$3.17

MiMedx Group, Inc (MDXG) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Form Type:

Show entries

Search:

Date	Form Type	View
2020-11-05	4 (Statement of changes in beneficial ownership of securities)
2020-11-05	4 (Statement of changes in beneficial ownership of securities)
2020-11-04	10-Q (Quarterly report [Sections 13 or 15(d)])
2020-11-04	8-K (Current report)
2020-11-03	CERT (Certification)
2020-11-02	8-A12B (Registration of securities [Section 12(b)])
2020-10-30	8-K (Current report)
2020-10-28	4 (Statement of changes in beneficial ownership of securities)
2020-10-22	8-K (Current report)
2020-10-15	DEF 14A (Other definitive proxy statements)
2020-10-15	DEFA14A (Additional definitive proxy soliciting materials and Rule 14(a)(12) material)
2020-10-05	8-K/A (Current report)
2020-10-05	PRE 14A (Other preliminary proxy statements)
2020-10-05	4 (Statement of changes in beneficial ownership of securities)
2020-10-05	4 (Statement of changes in beneficial ownership of securities)
2020-10-05	4 (Statement of changes in beneficial ownership of securities)
2020-10-05	4 (Statement of changes in beneficial ownership of securities)
2020-10-05	4 (Statement of changes in beneficial ownership of securities)
2020-10-05	4 (Statement of changes in beneficial ownership of securities)
2020-10-05	4 (Statement of changes in beneficial ownership of securities)

MiMedx Group, Inc (MDXG) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of MiMedx Group, Inc (MDXG). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 637%
Institutional Ownership: 1210%

Show entries

Search:

Transaction Date	Insider Name	Insider Title	Type	Shares Number	Shares Price	Total Transaction	Shares Held After Transaction
2020-11-04	Peter M Carlson	Chief Financial Officer	Buy	35,211.00	7.23	254,575.53	297,683.00
2020-11-04	William Lawrence Phelan	Chief Accounting Officer	Buy	8,474.00	7.23	61,267.02	67,796.00
2020-10-02	Charles Robert Evans	Director	Buy	26,236.00	6.67	174,994.12	121,357.00
2020-10-02	NEIL YESTON	Director	Buy	26,236.00	6.67	174,994.12	126,357.00
2020-10-02	CHARLES E KOOB	Director	Buy	26,236.00	6.67	174,994.12	1,431,525.00
2020-10-02	WILLIAM A HAWKINS	Director	Buy	26,236.00	6.67	174,994.12	39,654.00
2020-10-02	JAMES L BIERMAN	Director	Buy	26,236.00	6.67	174,994.12	64,371.00
2020-10-02	M KATHLEEN BEHRENS	Director	Buy	26,236.00	6.67	174,994.12	64,371.00
2020-10-02	Todd Newton	Director	Buy	26,236.00	6.67	174,994.12	64,371.00
2020-08-10	Robert Benjamin Stein	EVP, Research and Development	Buy	81,833.00	6.11	499,999.63	81,833.00
2020-08-05	NEIL YESTON	Director	Buy	29,661.00			100,121.00
2020-08-05	TIMOTHY R WRIGHT	Chief Executive Officer	Buy	572,033.00			1,164,260.00
2020-08-05	William Frank IV Hulse	General Counsel	Buy	120,762.00			120,762.00
2020-08-05	CHARLES E KOOB	Director	Buy	29,661.00			1,505,289.00
2020-08-05	Scott M Turner	SVP, Operations & Procurement	Buy	48,135.00			152,978.00
2020-08-05	J TERRY DEWBERRY	Director	Buy	29,661.00			156,787.00
2020-08-05	Peter M Carlson	Chief Financial Officer	Buy	177,966.00			262,472.00
2020-08-05	Richard Barry	Director	Buy	38,135.00			3,338,135.00
2020-08-05	JAMES L BIERMAN	Director	Buy	38,135.00			38,135.00
2020-08-05	M KATHLEEN BEHRENS	Director	Buy	38,135.00			38,135.00

MiMedx Group, Inc

(NASDAQ:MDXG)

$6.76

STRONG BUY

Latest On MiMedx Group, Inc (MDXG):

About MiMedx Group, Inc (MDXG):

General

Valuation

Financials

Highlights

Share Statistics

Technicals

Dividends

MiMedx Group, Inc (MDXG) Dividend Calendar:

MiMedx Group, Inc (MDXG) Earnings History:

MiMedx Group, Inc (MDXG) Company Financial Statements:

Income Statement:

Cash Flow:

Balance Sheet:

MiMedx Group, Inc (MDXG) Chart:

MiMedx Group, Inc (MDXG) News:

MiMedx Group, Inc (MDXG) Options:

Latest MDXG Trades:

MiMedx Group, Inc (MDXG) SEC Filings:

MiMedx Group, Inc (MDXG) Insider Transactions: